FDA Inspection 1314330 - Altaire Pharmaceuticals, Inc. - April 21, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Altaire Pharmaceuticals, Inc., with an inspection on April 21, 2026, issued by the New York District Office, covering human drugs.

Company: Altaire Pharmaceuticals, Inc.
Inspection Date: April 21, 2026
Product Type: Human Drugs
Office: New York District Office

Open in Dashboard

ID · 41e19a6e-ba33-47a8-ad24-842a94d518b4

Violation Codes8

21 CFR 211.100(a)21 CFR 211.113(b)21 CFR 211.19221 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)21 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.